# rs7001688 and LDL cholesterol

Configuration `single`, named mode, seed 0. Models: generator openai/gpt-6-luna, critic openai/gpt-6-luna, summariser openai/gpt-6-luna. Cost $0.00 over 1 model calls; 57 s.

Variant `chr8:57573391:G>T` (germline); expression context: DepMap:ACH-000625 (Hep 3B2.1-7).

## Ranked chains

### 1. H0: No TF-mediated effect of rs7001688 (p = 0.60)

Null chain: no TF-mediated effect of this variant.

Predictions: The ref and alt alleles show no reproducible difference in TF binding or in CYP7A1 expression attributable to this variant.; The LDL association, if real, could reflect linkage to another causal variant or another non-TF mechanism.

Falsified if: A reproducible allele-dependent TF-binding effect is shown at this site and linked to a corresponding change in target-gene expression and LDL-related function.

### 2. H1: Alt allele strengthens HNF4A binding and increases CYP7A1 expression (p = 0.20)

TF HNF4A (QBiC-SELEX coverage own_model), alt allele binds more; element A hypothetical cis-regulatory element containing rs7001688; gene CYP7A1; cell type Hep3B2.1-7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | Hypothesis: the alt T allele binds HNF4A more strongly than ref G; no occupancy or QBiC-SELEX result was supplied, so this direction is an unverified prediction. HNF4A is proposed because it is a liver-enriched regulator, not because variant-specific evidence identifies it over related factors. | missing | none |
| element | The variant lies in a cis-regulatory element active in Hep3B2.1-7 cells; this element assignment is unverified. | missing | none |
| gene | The element increases CYP7A1 expression when HNF4A binds more strongly; the variant-to-gene link is unverified. | missing | none |
| cell_type | The proposed effect occurs in the Hep3B2.1-7 liver-derived cell context. | missing | none |
| phenotype | If increased CYP7A1 activity increases hepatic conversion of cholesterol to bile acids, this chain predicts lower LDL cholesterol; the net effect on LDL is uncertain. | missing | none |

Predictions: An allele-specific HNF4A binding assay will show greater binding to alt than ref.; If the chain is correct, an isogenic alt allele will increase CYP7A1 expression relative to ref.

Falsified if: HNF4A shows no reproducible allele-specific binding difference under relevant conditions, or the alt allele does not increase CYP7A1 expression when tested in an appropriate cell context.

### 3. H2: Ref allele strengthens FOXA2 binding and increases CYP7A1 expression (p = 0.12)

TF FOXA2 (QBiC-SELEX coverage own_model), ref allele binds more; element A hypothetical cis-regulatory element containing rs7001688; gene CYP7A1; cell type Hep3B2.1-7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | Hypothesis: the ref G allele binds FOXA2 more strongly than alt T; no occupancy or QBiC-SELEX result was supplied, so this direction is an unverified prediction. FOXA2 is considered as a liver-associated DNA-binding factor, but the supplied information does not distinguish it from related factors. | missing | none |
| element | The variant lies in a cis-regulatory element active in Hep3B2.1-7 cells; this element assignment is unverified. | missing | none |
| gene | The element increases CYP7A1 expression when FOXA2 binds more strongly; the variant-to-gene link is unverified. | missing | none |
| cell_type | The proposed effect occurs in the Hep3B2.1-7 liver-derived cell context. | missing | none |
| phenotype | If increased CYP7A1 activity increases hepatic conversion of cholesterol to bile acids, this chain predicts lower LDL cholesterol; the net effect on LDL is uncertain. | missing | none |

Predictions: An allele-specific FOXA2 binding assay will show greater binding to ref than alt.; An isogenic ref allele will increase CYP7A1 expression relative to alt if this chain is correct.

Falsified if: FOXA2 shows no reproducible allele-specific binding difference under relevant conditions, or the ref allele does not increase CYP7A1 expression when tested in an appropriate cell context.

### 4. H3: Alt allele strengthens CEBPA binding and represses CYP7A1 (p = 0.08)

TF CEBPA (QBiC-SELEX coverage own_model), alt allele binds more; element A hypothetical cis-regulatory element containing rs7001688; gene CYP7A1; cell type Hep3B2.1-7.

| Step | Claim | Status | Evidence |
| --- | --- | --- | --- |
| binding | Hypothesis: the alt T allele binds CEBPA more strongly than ref G; no occupancy or QBiC-SELEX result was supplied, so this direction is an unverified prediction. CEBPA is considered as a liver-associated factor, but there is no variant-specific evidence selecting it over related factors. | missing | none |
| element | The variant lies in a cis-regulatory element active in Hep3B2.1-7 cells; this element assignment is unverified. | missing | none |
| gene | The element represses CYP7A1 expression when CEBPA binds more strongly; this regulatory direction and the variant-to-gene link are unverified. | missing | none |
| cell_type | The proposed effect occurs in the Hep3B2.1-7 liver-derived cell context. | missing | none |
| phenotype | If reduced CYP7A1 activity reduces hepatic conversion of cholesterol to bile acids, this chain predicts higher LDL cholesterol; the net effect on LDL is uncertain. | missing | none |

Predictions: An allele-specific CEBPA binding assay will show greater binding to alt than ref.; An isogenic alt allele will reduce CYP7A1 expression relative to ref if this chain is correct.

Falsified if: CEBPA shows no reproducible allele-specific binding difference under relevant conditions, or the alt allele does not reduce CYP7A1 expression when tested in an appropriate cell context.

## Prediction matrix

| Test | Cost | Separates top two | H0 | H1 | H2 | H3 |
| --- | --- | --- | --- | --- | --- | --- |
| Allele-specific EMSA using ref and alt probes with HNF4A, FOXA2, and CEBPA individually, with a factor-specific supershift or equivalent specificity control | low | yes | No reproducible allele-specific shift for the candidate factors. | HNF4A-specific shift is stronger with the alt probe. | FOXA2-specific shift is stronger with the ref probe. | CEBPA-specific shift is stronger with the alt probe. |

## Next experiment

Run the allele-specific EMSA with HNF4A, FOXA2, and CEBPA separately and factor-specific controls. It is the lowest-cost direct test of the leading HNF4A binding hypothesis against the null; a positive result would still require follow-up to establish occupancy, target-gene regulation, and relevance to LDL.

## Flags

- none

## Evidence
